We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 82

Parameteritis pokes holes in Swiss-type claim
  • Minter Ellison
  • Australia
  • December 2 2016

The Full Federal Court has recently handed down its decision in the appeal by Otsuka Pharmaceutical Co (Otsuka) against the earlier finding by


The new exclusive club of patent enforcement
  • Minter Ellison
  • Australia
  • November 8 2016

In a relatively recent flurry of decisions, the Federal Court examined a variety of agreements purporting to give exclusive rights to various


Planning for privacy in health research
  • Minter Ellison
  • Australia
  • August 8 2016

Information is critical to the conduct of health and medical research. Much of the time the information relates to individuals. Higher education


Omnibus claims: Back to business as usual
  • Minter Ellison
  • Australia
  • July 19 2016

The Full Federal Court has recently handed down its decision in the appeal by GlaxoSmithKline (GSK) against the earlier finding by Justice Rares


Update: Servier successful in stay application - Apotex kept off the market while Servier appeals to the High Court
  • Minter Ellison
  • Australia
  • March 31 2016

Servier was successful in yesterday's hearing of its stay application. As a result, the orders which revoked Servier's patent and discharged the


"Just DAST it" - Gilead succeeds on insufficiency and inutility for Hepatitis C treatment
  • Minter Ellison
  • Australia
  • March 29 2016

Gilead commenced proceedings against Idenix seeking revocation of Idenix's Australian patent No 2003247084 (Patent). The Patent was filed on 27 June


Servier fails on best method - Full Federal Court confirms invalidity and denies application to amend
  • Minter Ellison
  • Australia
  • March 18 2016

This decision is interesting as it deals with four pertinent topics - the best method requirement patent amendment applications cost


Health & Ageing sector - increasing investment opportunities
  • Minter Ellison
  • Australia, China
  • February 26 2016

Increased deal activity is likely in Australia's health and aged care sector in 2016, driven by: investment interest from China Australian players


Exclusive patent licences and standing to sue - a green light for commercial 'work arounds'
  • Minter Ellison
  • Australia
  • December 21 2015

In Orion Corporation v Actavis Pty Ltd (No 3) 2015 FCA 1373, the Federal Court has provided practical guidance on drafting an exclusive patent


2015 Patent recap: The 8 (patent) days of Christmas
  • Minter Ellison
  • Australia
  • December 9 2015

The High Court of Australia rarely considers patent cases, handing down only two decisions in the past seven years. This year, however, we saw two